ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 249 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,175,110 | -12.1% | 1,303,988 | +1.0% | 1.64% | -2.2% |
| Q2 2023 | $30,921,701 | +36.1% | 1,291,094 | +6.9% | 1.68% | +25.0% |
| Q1 2023 | $22,721,424 | +36.1% | 1,207,302 | +15.1% | 1.34% | +29.8% |
| Q4 2022 | $16,696,100 | -1.2% | 1,048,750 | +1.6% | 1.03% | -3.2% |
| Q3 2022 | $16,896,000 | +56.3% | 1,032,739 | +34.7% | 1.07% | +70.6% |
| Q2 2022 | $10,807,000 | -31.4% | 766,971 | +18.0% | 0.63% | -10.1% |
| Q1 2022 | $15,743,000 | -4.7% | 649,993 | -8.2% | 0.70% | +19.6% |
| Q4 2021 | $16,524,000 | – | 707,969 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |